Catalys Pacific, LLC has filed its 13F form on August 13, 2024 for Q2 2024 where it was disclosed a total value porftolio of $132 Billion distributed in 3 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Mineralys Therapeutics, Inc. with a value of $108B, Hille Vax, Inc. with a value of $17.5B, and Phathom Pharmaceuticals, Inc. with a value of $7.44B.

Examining the 13F form we can see an decrease of $15.6B in the current position value, from $148B to 132B.

Catalys Pacific, LLC is based out at Tokyo, M0

Below you can find more details about Catalys Pacific, LLC portfolio as well as his latest detailed transactions.

Portfolio value $132 Billion
Healthcare: $24.9 Billion

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 3
  • Current Value $132 Billion
  • Prior Value $148 Billion
  • Filing
  • Period Q2 2024
  • Filing Date August 13, 2024
  • Form Type 13F-HR
  • Activity in Q2 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 1 stocks
Track This Portfolio

Track Catalys Pacific, LLC Portfolio

Follow Catalys Pacific, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalys Pacific, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Catalys Pacific, LLC with notifications on news.